Literature DB >> 19147652

MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue.

Sashwati Roy1, Savita Khanna, Syed-Rehan A Hussain, Sabyasachi Biswas, Ali Azad, Cameron Rink, Surya Gnyawali, Shani Shilo, Gerard J Nuovo, Chandan K Sen.   

Abstract

AIMS: MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression at the post-transcriptional level by either degradation or translational repression of a target mRNA. Encoded in the genome of most eukaryotes, miRNAs have been proposed to regulate specifically up to 90% of human genes through a process known as miRNA-guided RNA silencing. For the first time, we sought to test how myocardial ischaemia-reperfusion (IR) changes miR expression. METHODS AND
RESULTS: Following 2 and 7 h of IR or sham operation, myocardial tissue was collected and subjected to miRNA expression profiling and quantification using a Bioarray system that screens for human-, mice-, rat-, and Ambi-miR. Data mining and differential analyses resulted in 13 miRs that were up-regulated on day 2, 9 miRs that were up-regulated on day 7, and 6 miRs that were down-regulated on day 7 post-IR. Results randomly selected from expression profiling were validated using real-time PCR. Tissue elements laser-captured from the infarct site showed marked induction of miR-21. In situ hybridization studies using locked nucleic acid miR-21-specific probe identified that IR-inducible miR-21 was specifically localized in the infarct region of the IR heart. Immunohistochemistry data show that cardiac fibroblasts (CFs) are the major cell type in the infarct zone. Studies with isolated CFs demonstrated that phosphatase and tensin homologue (PTEN) is a direct target of miR-21. Modulation of miR-21 regulated expression of matrix metalloprotease-2 (MMP-2) via a PTEN pathway. Finally, we noted a marked decrease in PTEN expression in the infarct zone. This decrease was associated with increased MMP-2 expression in the infarct area.
CONCLUSION: This work constitutes the first report describing changes in miR expression in response to IR in the mouse heart, showing that miR-21 regulates MMP-2 expression in CFs of the infarct zone via a PTEN pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19147652      PMCID: PMC2652741          DOI: 10.1093/cvr/cvp015

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  35 in total

Review 1.  Protein interactions and complexes in human microRNA biogenesis and function.

Authors:  Marjorie P Perron; Patrick Provost
Journal:  Front Biosci       Date:  2008-01-01

2.  Inhibiting PTEN.

Authors:  E Rosivatz
Journal:  Biochem Soc Trans       Date:  2007-04       Impact factor: 5.407

Review 3.  PTEN, the Achilles' heel of myocardial ischaemia/reperfusion injury?

Authors:  M M Mocanu; D M Yellon
Journal:  Br J Pharmacol       Date:  2007-02-12       Impact factor: 8.739

4.  Transgenic MMP-2 expression induces latent cardiac mitochondrial dysfunction.

Authors:  Hui-Zhong Zhou; Xiaokui Ma; Mary O Gray; Bo-qing Zhu; Anita P Nguyen; Anthony J Baker; Ursula Simonis; Gary Cecchini; David H Lovett; Joel S Karliner
Journal:  Biochem Biophys Res Commun       Date:  2007-04-23       Impact factor: 3.575

5.  STAT3-dependent mouse embryonic stem cell differentiation into cardiomyocytes: analysis of molecular signaling and therapeutic efficacy of cardiomyocyte precommitted mES transplantation in a mouse model of myocardial infarction.

Authors:  Johnson Rajasingh; Evelyn Bord; Hiromichi Hamada; Erin Lambers; Gangjian Qin; Douglas W Losordo; Raj Kishore
Journal:  Circ Res       Date:  2007-09-06       Impact factor: 17.367

6.  Matrix metalloproteinase-2 degrades the cytoskeletal protein alpha-actinin in peroxynitrite mediated myocardial injury.

Authors:  Miranda M Sung; Christina G Schulz; Wenjie Wang; Grzegorz Sawicki; Norma L Bautista-López; Richard Schulz
Journal:  J Mol Cell Cardiol       Date:  2007-07-31       Impact factor: 5.000

7.  Transcriptome-wide analysis of blood vessels laser captured from human skin and chronic wound-edge tissue.

Authors:  Sashwati Roy; Darshan Patel; Savita Khanna; Gayle M Gordillo; Sabyasachi Biswas; Avner Friedman; Chandan K Sen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-29       Impact factor: 11.205

8.  P21waf1/cip1/sdi1 as a central regulator of inducible smooth muscle actin expression and differentiation of cardiac fibroblasts to myofibroblasts.

Authors:  Sashwati Roy; Savita Khanna; Trenton Rink; Jared Radtke; W Taylor Williams; Sabyasachi Biswas; Rebecca Schnitt; Arthur R Strauch; Chandan K Sen
Journal:  Mol Biol Cell       Date:  2007-09-19       Impact factor: 4.138

9.  Nerve growth factor induces endothelial cell invasion and cord formation by promoting matrix metalloproteinase-2 expression through the phosphatidylinositol 3-kinase/Akt signaling pathway and AP-2 transcription factor.

Authors:  Myung-Jin Park; Hee-Jin Kwak; Hyung-Chahn Lee; Doo-Hyun Yoo; In-Chul Park; Mi-Suk Kim; Seung-Hoon Lee; Chang Hun Rhee; Seok-Il Hong
Journal:  J Biol Chem       Date:  2007-07-31       Impact factor: 5.157

10.  MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer.

Authors:  Fanyin Meng; Roger Henson; Hania Wehbe-Janek; Kalpana Ghoshal; Samson T Jacob; Tushar Patel
Journal:  Gastroenterology       Date:  2007-05-21       Impact factor: 22.682

View more
  249 in total

1.  MicroRNAs: Novel Regulators of the Heart.

Authors:  Junjie Xiao; Yi-Han Chen
Journal:  J Thorac Dis       Date:  2010-03       Impact factor: 2.895

Review 2.  MicroRNA in ischemic stroke etiology and pathology.

Authors:  Cameron Rink; Savita Khanna
Journal:  Physiol Genomics       Date:  2010-09-14       Impact factor: 3.107

Review 3.  miRNAs as therapeutic targets in ischemic heart disease.

Authors:  Robert J A Frost; Eva van Rooij
Journal:  J Cardiovasc Transl Res       Date:  2010-03-30       Impact factor: 4.132

4.  miR-200b targets Ets-1 and is down-regulated by hypoxia to induce angiogenic response of endothelial cells.

Authors:  Yuk Cheung Chan; Savita Khanna; Sashwati Roy; Chandan K Sen
Journal:  J Biol Chem       Date:  2010-11-16       Impact factor: 5.157

5.  Relationship between the temporal profile of plasma microRNA and left ventricular remodeling in patients after myocardial infarction.

Authors:  Michael R Zile; Shannon M Mehurg; Jazmine E Arroyo; Robert E Stroud; Stacia M DeSantis; Francis G Spinale
Journal:  Circ Cardiovasc Genet       Date:  2011-09-28

Review 6.  Diagnostic and prognostic value of circulating microRNAs in heart failure with preserved and reduced ejection fraction.

Authors:  Christian Schulte; Dirk Westermann; Stefan Blankenberg; Tanja Zeller
Journal:  World J Cardiol       Date:  2015-12-26

Review 7.  MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine.

Authors:  V Sala; S Bergerone; S Gatti; S Gallo; A Ponzetto; C Ponzetto; T Crepaldi
Journal:  Cell Mol Life Sci       Date:  2013-11-12       Impact factor: 9.261

8.  The Cardiotoxic Mechanism of Doxorubicin (DOX) and Pegylated Liposomal DOX in Mice Bearing C-26 Colon Carcinoma: a Study Focused on microRNA Role for Toxicity Assessment of New Formulations.

Authors:  Kamal Razavi-Azarkhiavi; Mahmoud Reza Jaafari; Khalil Abnous; Bibi Marjan Razavi; Amir Hossein Jafarian; Faezeh Vahdati Hassani; Kobra Shirani; Gholamreza Karimi
Journal:  Pharm Res       Date:  2017-05-30       Impact factor: 4.200

9.  microRNA-21 promotes cardiac fibrosis and development of heart failure with preserved left ventricular ejection fraction by up-regulating Bcl-2.

Authors:  Shuguang Dong; Wenhan Ma; Bohan Hao; Fen Hu; Lianhua Yan; Xiaofei Yan; Ya Wang; Zhijian Chen; Zhaohui Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

10.  Human skin wounds: a major and snowballing threat to public health and the economy.

Authors:  Chandan K Sen; Gayle M Gordillo; Sashwati Roy; Robert Kirsner; Lynn Lambert; Thomas K Hunt; Finn Gottrup; Geoffrey C Gurtner; Michael T Longaker
Journal:  Wound Repair Regen       Date:  2009 Nov-Dec       Impact factor: 3.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.